FORE GENOMICS Trademark

Trademark Overview

On Tuesday, November 22, 2022, a trademark application was filed for FORE GENOMICS with the United States Patent and Trademark Office. The USPTO has given the FORE GENOMICS trademark a serial number of 97689002. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, March 7, 2024. This trademark is owned by Fore Genomics, Inc.. The FORE GENOMICS trademark is filed in the Pharmaceutical Products category with the following description:

Whole genome sequencing tests, namely, for medical, health, and diagnostic purposes, designed for healthy children
fore genomics

General Information

Serial Number97689002
Word MarkFORE GENOMICS
Filing DateTuesday, November 22, 2022
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, March 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesWhole genome sequencing tests, namely, for medical, health, and diagnostic purposes, designed for healthy children
Disclaimer with Predetermined Text"GENOMICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, November 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFore Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92101

Trademark Events

Event DateEvent Description
Thursday, March 7, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2024LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2024SUSPENSION LETTER WRITTEN
Thursday, February 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 28, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, November 28, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, August 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2023NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2023NON-FINAL ACTION WRITTEN
Sunday, August 27, 2023ASSIGNED TO EXAMINER
Wednesday, August 9, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, August 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 9, 2023ASSIGNED TO LIE
Thursday, March 30, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, March 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 25, 2022NEW APPLICATION ENTERED

Related Keywords

genomics fore purposes diagnostic designed healthy children health medical genome sequencing tests